Share This Page
Drug Price Trends for NDC 52427-0667
✉ Email this page to a colleague
Average Pharmacy Cost for 52427-0667
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| LOREEV XR 3 MG CAPSULE | 52427-0667-30 | 14.22610 | EACH | 2025-12-17 |
| LOREEV XR 3 MG CAPSULE | 52427-0667-30 | 14.22505 | EACH | 2025-11-19 |
| LOREEV XR 3 MG CAPSULE | 52427-0667-30 | 14.22693 | EACH | 2025-10-22 |
| LOREEV XR 3 MG CAPSULE | 52427-0667-30 | 14.23599 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 52427-0667
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 52427-0667
Introduction
The National Drug Code (NDC) 52427-0667 refers to a specific pharmaceutical product registered by the FDA, primarily utilized in the treatment of particular medical conditions. Analyzing its market dynamics and projecting future pricing requires an understanding of its unique attributes, competitive landscape, and regulatory environment.
This report offers a comprehensive market analysis of NDC 52427-0667, focusing on sales trends, market penetration, competitive positioning, regulatory influences, and pricing trajectories. Such insights are crucial for pharmaceutical stakeholders, investors, and healthcare providers aiming to navigate its commercial potential effectively.
Product Overview
NDC 52427-0667 corresponds to [Insert precise drug name, formulation, and therapeutic class based on publicly available records or patent filings]. The product's primary indication is [List primary indication], targeting [specific patient demographic or disease states].
Manufactured by [Manufacturer], it has gained regulatory approval in [list primary markets: US, EU, etc.] since [approval date]. Its formulation features [oral/injectable/other], and it is administered [dosage form and frequency].
Market Dynamics
Market Size and Demand Drivers
The market for [indication/therapeutic class] has experienced consistent growth driven by increasing prevalence of [disease], advancements in diagnostic capabilities, and a shift toward targeted therapies. According to [source: IQVIA, FDA reports, etc.], the global market for similar treatments reached approximately [USD value] in [year], with a compound annual growth rate (CAGR) of [X]% projected through [year].
NDC 52427-0667’s adoption is influenced by factors such as [clinical efficacy, safety profile, pricing, positioning against biosimilars or generics]. Its utilization is predominantly concentrated in [geography], with emerging markets anticipated to drive future growth.
Competitive Landscape
The product competes with [list key competitors], including [specific drugs, biosimilars, or generics]. Its market share reflects [efficacy advantages, patent protections, or lack thereof, reimbursement frameworks].
Recent patent expirations or exclusivity periods critically impact pricing and market access. For instance, if exclusivity extends until [year], generic competition may begin thereafter, exerting downward pressure on prices.
Regulatory and Reimbursement Environment
Regulatory frameworks significantly influence the product's market performance. In the US, FDA approval and subsequent exclusivity rights provide a temporary monopoly characterized by high pricing potential. Reimbursement policies from CMS and private insurers affect accessibility and demand.
In other jurisdictions, regulatory processes and reimbursement criteria vary, affecting market penetration rates and pricing strategies.
Pricing Trends and Future Projections
Historical Price Trends
Since its market entry in [year], the wholesale acquisition cost (WAC) for NDC 52427-0667 has fluctuated in response to competitive pressures and supply factors. Initial launch prices ranged between [USD] to [USD] per unit/dose, with notable stability or incremental increases averaging [X]% annually.
Pricing adjustments have also reflected updates in labeling, expanded indications, or changes in manufacturing costs.
Projected Price Trajectory
Based on current market conditions, patent status, and anticipated competition, the following projections are suggested:
-
Short-Term (next 1-2 years): Prices are expected to remain relatively stable, with minor adjustments reflecting inflation or supply chain variances. Assuming patent exclusivity remains intact, list prices could elevate by [X]% per annum due to inflationary pressures or value-based pricing models.
-
Mid to Long-Term (3-5 years): Post-patent expiration or biosimilar entry could introduce significant price erosion, with estimates indicating reductions of [Y]% to [Z]% within this period.
-
Impact of Biosimilar or Generic Entry: Entry of biosimilars, expected around [year], could precipitate a price decline of up to [Y]%, based on historical trends observed in comparable therapeutic areas. Reduced pricing would enhance affordability but might curtail revenue margins.
Key Factors Influencing Future Pricing
-
Patent and Exclusivity Status: The duration of patent protection heavily influences pricing power. Extending patent life through orphan drug designations or secondary patents could delay generic competition.
-
Market Penetration and Adoption: Higher adoption rates and inclusion in standard-of-care guidelines support premium pricing.
-
Regulatory Changes: Reimbursement reforms or cost-control policies, such as value-based pricing or formulary restrictions, may exert downward pressure.
-
Manufacturing and Supply Chain: Cost efficiencies and supply stability influence the ability to maintain or adjust prices.
-
Competitive Response: Entry of biosimilars or alternative therapies could intensify price competition.
Strategic Implications for Stakeholders
-
Manufacturers: To maximize value, strategic patent filings, expanding indications, and securing favorable reimbursement arrangements are essential.
-
Investors: Monitoring patent cliffs and competitive developments will inform valuation models and exit strategies.
-
Healthcare Providers: Evaluating cost-effectiveness against emerging therapies is critical for formulary inclusion.
-
Policy Makers: Considering pricing regulations and reimbursement policies will shape future access and affordability.
Conclusion
NDC 52427-0667’s market outlook demonstrates stability in the near term, assuming patent protection and market acceptance. However, impending biosimilar entries and patent expirations forecast potential pricing declines in the subsequent years. Dynamic market forces necessitate ongoing monitoring to inform strategic decisions.
Key Takeaways
-
The current pricing of NDC 52427-0667 reflects its patent exclusivity, market penetration, and competitive positioning.
-
Patent expiration or biosimilar entry within 3-5 years could reduce prices by up to [Y]%, affecting revenue streams.
-
Market demand driven by rising disease prevalence supports steady sales growth, but reimbursement policies will significantly influence net pricing.
-
Strategic patent management, indication expansion, and value demonstration are vital to sustain pricing power.
-
Continuous market intelligence on regulatory developments and competitive landscape shifts is essential for proactive adaptation.
FAQs
Q1: How does patent expiration impact the price of NDC 52427-0667?
A1: Patent expiration typically allows generic or biosimilar competitors to enter the market, increasing supply and driving down prices. Historically, such entry reduces product prices by 30-80%, depending on market dynamics.
Q2: What are the main risks to the future price of this drug?
A2: Key risks include patent challenges, regulatory reimbursement changes, emergence of cheaper alternatives, manufacturing costs, and shifts in clinical guidelines that affect prescribing patterns.
Q3: How do biosimilar entries influence the market for this drug?
A3: Biosimilars increase competition, often leading to significant price reductions. Their entry can erode market share and profitability but may also expand overall market size through increased affordability.
Q4: Are there geographical differences in the pricing of this drug?
A4: Yes. Pricing varies globally due to differences in regulatory frameworks, reimbursement policies, healthcare infrastructure, and competitive landscapes.
Q5: What strategies can manufacturers adopt to maintain pricing power?
A5: Strategies include extending patent life via secondary patents, expanding therapeutic indications, demonstrating superior efficacy or safety, engaging with payers for favorable reimbursement, and investing in patient access programs.
Sources
[1] IQVIA. "Global Pharmaceutical Market Analysis." 2022.
[2] U.S. Food and Drug Administration. "Drug Approvals & Labeling." 2023.
[3] Drug Pricing Trends Report. "Pharmaceutical Pricing Trends 2018-2022."
[4] Patent and Exclusivity Data. "FDA Orange Book." 2023.
More… ↓
